Profile cover photo
Profile photo
MedCareer News
39 followers -
Get the latest Medical Career news and advice.
Get the latest Medical Career news and advice.

39 followers
About
Posts

Post has attachment

Post has attachment

Post has shared content

Post has shared content
The Phase 3 study compared abemaciclib in combination with an aromatase inhibitor versus an aromatase inhibitor alone in patients with HR+, HER2- advanced breast cancer INDIANAPOLIS, April 24, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today…
Add a comment...

Post has shared content
Paxman Scalp Cooler, a system developed to reduce the risk for hair loss in cancer patients undergoing chemotherapy, has now been cleared by the US Food and Drug Administration (FDA). As part of the FDA clearance process, the Paxman scalp cooler was used…
Add a comment...

Post has shared content
FDA expands approved use of Stivarga to treat liver cancer The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been…
Add a comment...

Post has shared content
Come July, the yellow fever vaccine could be tough to find. So, if you’re traveling this summer to a place with the disease, you probably want to schedule a trip to a clinic sooner rather than later, the Centers for Diseases for Control and Prevention…
Add a comment...

Post has shared content
Exclusive license for emricasan supports rapidly growing development portfolio in chronic liver diseases, including NASH Conatus has initiated the Phase IIb ENCORE-LF clinical trial with emricasan in NASH. If positive, Novartis would conduct Phase III…
Add a comment...

Post has shared content
Is it your dream to land a job as a pharmaceutical sales representative, but you do not know where to begin. Maybe you have not put a resume together since you graduated college. You have been told that you can only get into pharmaceutical sales if you…
Add a comment...

Post has shared content
The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. “After learning about the use of edaravone to treat ALS in Japan, we…
Add a comment...
Wait while more posts are being loaded